Outcome analysis revealed a tight relationship between eGFR slope and graft survival, showing a highly significant increase (by 6%) in the risk of graft loss for each 1 ml/min/1.73 m 2 decease in eGFR at 3 years postsubclinical de novo DSA onset 27 .
← all excerpts
The therapeutic challenge of late antibody-mediated kidney allograft rejection.
1
—
—